Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG with Reflex to Type 1 and 2 Glycoprotein G-Specific Ab, IgG
Preferred testing for herpes simplex virus (HSV) when exposure to HSV is suspected.
May be useful in identifying a subclinical HSV infection. If results are positive for HSV type 1/2 combined antibodies but negative for both type-specific antibodies, follow-up testing at least one month later is recommended because glycoprotein antibodies may require 3-6 months to form; refer to Herpes Simplex Type 1 and Type 2 Glycoprotein G-Specific Antibodies, IgG by CIA (0051152).
Semi-Quantitative Chemiluminescent Immunoassay
New York DOH Approval Status
Serum separator tube.
Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of acute specimens. Mark specimens plainly as "acute" or "convalescent."
Plasma or urine. Contaminated, heat-inactivated, hemolyzed, or severely lipemic specimens.
Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year
|Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG by Chemiluminescent Immunoassay||0.89 IV or less: Not Detected.
0.90-1.09 IV: Indeterminate - Repeat testing in 10-14 days may be helpful.
1.10 IV or greater: Detected.
If HSV 1 and/or 2 IgG is 1.10 IV or greater, then HSV 1 gG-Specific IgG and HSV 2 gG-Specific IgG will be added. Additional charges apply.
86694; if reflexed, add 86695; 86696
|Component Test Code*||Component Chart Name||LOINC|
|0050286||HSV Type 1/2 Combined Ab, IgG||27948-9|
- glycoprotein type-specific reactivity
- Herpes Simplex Antibodies, IgG
- Herpes Simplex Serology, Serum HSV 1,2
- HSV 1, 2 IgG
- HSV 1,2
- HSV 1,2 glycoprotein
- HSV glycoprotein G
- HSV glycoprotein G-based type-specific serology